Starting from the observations that, in our series, MMR defects were more prevalent in the TP53-mutated group and that this molecular group also showed the highest rate of mutations, it is reasonable to hypothesize that this subgroup bears, as compared to the other two subgroups, a molecular profile closer to the one of anaplastic carcinoma. The gene discussed is TP53; the disease is undifferentiated carcinoma.